Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 2, Pages 289
Publisher
MDPI AG
Online
2020-06-09
DOI
10.3390/vaccines8020289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis
- (2020) Patrícia A.F. Ribeiro et al. CYTOKINE
- Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study
- (2019) Jaya Chakravarty et al. PLoS Neglected Tropical Diseases
- The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia – A review and meta-analysis
- (2019) Joyce Pijpers et al. PLoS Neglected Tropical Diseases
- Host-mediated activity of miltefosine in leishmaniasis through immunomodulation: a systematic review
- (2019) Semra Palić et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls
- (2019) Danniele L. Vale et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Leishmania infantum β-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis
- (2019) Lourena E. Costa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages
- (2019) Jun Ye et al. International Journal of Nanomedicine
- Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach
- (2019) Daniela P. Lage et al. PARASITOLOGY
- Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
- (2019) Sneha Ratnapriya et al. VACCINE
- New Insights on the Adjuvant Properties of the Leishmania infantum Eukaryotic Initiation Factor
- (2019) Olga S. Koutsoni et al. Journal of Immunology Research
- Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21
- (2019) Amritha Ramakrishnan et al. mSphere
- Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
- (2019) Alti Dayakar et al. Frontiers in Immunology
- Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice
- (2019) Rory Cristiane Fortes De Brito et al. Vaccines
- Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis
- (2018) Daniel S. Dias et al. CELLULAR IMMUNOLOGY
- Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis
- (2018) Áquila S.B. Portela et al. IMMUNOBIOLOGY
- Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice
- (2018) Rodrigo Saar Gomes et al. INFECTION AND IMMUNITY
- Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle
- (2018) H. Noormehr et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans
- (2018) Mangala Rao et al. JOURNAL OF INFECTIOUS DISEASES
- Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis
- (2018) Partha Das et al. MICROBES AND INFECTION
- Vaccination with a CD4 + and CD8 + T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis
- (2018) Daniel S. Dias et al. Translational Research
- Immunotherapeutic potential of Leishmania ( Leishmania ) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis
- (2018) Keerti et al. VACCINE
- Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
- (2018) Abdus Sabur et al. Frontiers in Immunology
- A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis
- (2018) Patrícia A.F. Ribeiro et al. CYTOKINE
- Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides
- (2018) Maria Agallou et al. MOLECULAR IMMUNOLOGY
- A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
- (2018) Juliana B.T. Carnielli et al. EBioMedicine
- Immunization of Experimental Dogs With Salivary Proteins From Lutzomyia longipalpis, Using DNA and Recombinant Canarypox Virus Induces Immune Responses Consistent With Protection Against Leishmania infantum
- (2018) Melissa Moura Costa Abbehusen et al. Frontiers in Immunology
- Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection
- (2018) Patrícia A.F. Ribeiro et al. MOLECULAR IMMUNOLOGY
- Miltefosine-resistant Leishmania infantum strains with an impaired MT/ROS3 transporter complex retain amphotericin B susceptibility
- (2017) Annelies Mondelaers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine
- (2017) Qian Wang et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment
- (2017) Johanna K. Valenzuela-Oses et al. Materials Science & Engineering C-Materials for Biological Applications
- Chemotherapeutics of visceral leishmaniasis: present and future developments
- (2017) SHYAM SUNDAR et al. PARASITOLOGY
- Chemotherapy of leishmaniasis: present challenges
- (2017) SILVIA R. B. ULIANA et al. PARASITOLOGY
- Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis
- (2017) Daniel S. Dias et al. PARASITOLOGY
- A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum
- (2017) L. Pirdel et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine
- (2017) Maria Agallou et al. PLoS Neglected Tropical Diseases
- A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
- (2017) Marcus Vinícius Alves-Silva et al. Frontiers in Immunology
- A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis
- (2016) Vívian Tamietti Martins et al. ACTA TROPICA
- A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection
- (2016) Mariana C. Duarte et al. MOLECULAR IMMUNOLOGY
- Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein againstLeishmania infantumin BALB/c mice
- (2016) N. Mortazavidehkordi et al. PARASITE IMMUNOLOGY
- A recombinant chimeric protein composed of human and mice-specific CD4+and CD8+T-cell epitopes protects against visceral leishmaniasis
- (2016) V. T. Martins et al. PARASITE IMMUNOLOGY
- Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system
- (2016) Mariana Costa Duarte et al. PARASITOLOGY INTERNATIONAL
- Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis
- (2016) Mariana Costa Duarte et al. Revista da Sociedade Brasileira de Medicina Tropical
- Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study
- (2015) Mirella A. Cunha et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis
- (2015) Mariana C. Duarte et al. Clinical and Vaccine Immunology
- Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice
- (2015) Ankita Thakur et al. IMMUNOBIOLOGY
- Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens ofLeishmania donovanialong with saponin against murine visceral leishmaniasis
- (2015) H. Kaur et al. PARASITE IMMUNOLOGY
- A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis
- (2015) Vivian T. Martins et al. Parasites & Vectors
- Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection
- (2015) Romain Olekhnovitch et al. TRENDS IN PARASITOLOGY
- Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis
- (2015) Rajeev Nagill et al. Asian Pacific Journal of Tropical Medicine
- Immune responses during cutaneous and visceral leishmaniasis
- (2014) LUKASZ KEDZIERSKI et al. PARASITOLOGY
- Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
- (2013) Suman Rijal et al. CLINICAL INFECTIOUS DISEASES
- Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
- (2013) Noushin Saljoughian et al. PLoS Neglected Tropical Diseases
- The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen
- (2012) Ali Badiee et al. EXPERIMENTAL PARASITOLOGY
- In silico identification of conserved intercoding sequences in Leishmania genomes: Unraveling putative cis-regulatory elements
- (2012) E.J.R. Vasconcelos et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends
- (2012) Ali Badiee et al. VACCINE
- Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
- (2012) Om Prakash Singh et al. PLoS Neglected Tropical Diseases
- Liposomal vaccine delivery systems
- (2011) Malou Henriksen-Lacey et al. Expert Opinion on Drug Delivery
- Leishmaniacell surface prohibitin: role in host-parasite interaction
- (2009) Rohit Jain et al. CELLULAR MICROBIOLOGY
- The path to a successful vaccine adjuvant – ‘The long and winding road’
- (2009) Derek T. O’Hagan et al. DRUG DISCOVERY TODAY
- Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production
- (2009) Lúcio Roberto Castellano et al. HUMAN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started